Home Print this page Email this page
Users Online: 212
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
PERSPECTIVE
Year : 2020  |  Volume : 9  |  Issue : 5  |  Page : 62-67

Use of antiviral nanocoating in personal protective wear


Division of Nanoscience and Technology, Faculty of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India

Correspondence Address:
Dr. Asha Srinivasan
Division of Nanoscience and Technology, Faculty of Life Sciences, JSS Academy of Higher Education and Research, Mysuru - 570 015, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijhas.IJHAS_80_20

Rights and Permissions

The emergence of the new coronavirus and its associated fatalities are growing at an alarming rate causing unprecedented losses worldwide. As the coronavirus disease 2019 pandemic accelerates in India, access to basic personal protective wear such as masks for health-care workers and for the general public is a key concern. Aerosol transmission of biological particles such as viruses is only one of several routes of exposure for contagion of which personal protection such as masks must be used by the general public. The protection level offered by N95 and surgical masks is defined by the percent of ambient particles penetrating across the protective mask. Recent interventions in nanotechnology have effectuated need-based virus resistance masks developed by impregnating nanomaterials or nanocoatings in the mask to combat the virus and augment protection levels. The aim of this review will be to highlight the coherent strategies of using versatile nanomaterials as an effective antiviral material coated onto masks and understanding the mechanism of “virus-nanoparticle” interaction. This viricidal effect is made possible by the use of functionalized nanoparticles through the addition of biomolecule covers or modified surfaces capable of interacting with active sites present on the membrane (capsid) allowing the virus to be deactivated.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed317    
    Printed0    
    Emailed0    
    PDF Downloaded92    
    Comments [Add]    

Recommend this journal